Dr. Peter Bach is the first author on a new JAMA analysis of the benefits and harms of using low-dose CT screening  for lung cancer. The American College of Chest Physicians and the American Society of Clinical Oncology requested the systematic review to assist them in drawing up a clinical guideline.

Join us in discussing who might most benefit from being offered such screening, and what work remains to be done.

Links:

JAMA article (free)

Physician’s First Watch coverage of recent guidelines from the American Lung Assoc. (free)